Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells Jul 19, 2023 | HIV
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial Feb 28, 2022 | HIV
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice Jul 23, 2021 | COVID-19
